AU4815397A - Method of disrupting cellular adhesion - Google Patents

Method of disrupting cellular adhesion

Info

Publication number
AU4815397A
AU4815397A AU48153/97A AU4815397A AU4815397A AU 4815397 A AU4815397 A AU 4815397A AU 48153/97 A AU48153/97 A AU 48153/97A AU 4815397 A AU4815397 A AU 4815397A AU 4815397 A AU4815397 A AU 4815397A
Authority
AU
Australia
Prior art keywords
cellular adhesion
disrupting cellular
disrupting
adhesion
cellular
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU48153/97A
Inventor
Jack J Hawiger
Xue-Yan Liu
Sheila Timmons
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vanderbilt University
Original Assignee
Vanderbilt University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vanderbilt University filed Critical Vanderbilt University
Publication of AU4815397A publication Critical patent/AU4815397A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70546—Integrin superfamily
    • C07K14/70557—Integrin beta3-subunit-containing molecules, e.g. CD41, CD51, CD61
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70546—Integrin superfamily
    • C07K14/7055—Integrin beta1-subunit-containing molecules, e.g. CD29, CD49
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70546—Integrin superfamily
    • C07K14/70553—Integrin beta2-subunit-containing molecules, e.g. CD11, CD18
AU48153/97A 1996-10-15 1997-10-09 Method of disrupting cellular adhesion Abandoned AU4815397A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2842096P 1996-10-15 1996-10-15
US60028420 1996-10-15
PCT/US1997/018331 WO1998016241A1 (en) 1996-10-15 1997-10-09 Method of disrupting cellular adhesion

Publications (1)

Publication Number Publication Date
AU4815397A true AU4815397A (en) 1998-05-11

Family

ID=21843353

Family Applications (1)

Application Number Title Priority Date Filing Date
AU48153/97A Abandoned AU4815397A (en) 1996-10-15 1997-10-09 Method of disrupting cellular adhesion

Country Status (2)

Country Link
AU (1) AU4815397A (en)
WO (1) WO1998016241A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0009804A (en) * 1999-04-16 2002-04-16 Childrens Medical Center Adhesion modulating peptides and their uses
AU2005204275B2 (en) * 1999-06-28 2008-10-16 Inter-K Pty Limited A method of modulating integrin mediated cellular activity and agents useful for same
US8119594B1 (en) 1999-06-28 2012-02-21 Inter-K Pty Limited Method of modulating integrin mediated cellular activity and agents useful for same
AUPR230500A0 (en) 2000-12-22 2001-01-25 University Of Newcastle Research Associates Limited, The A method of modulating map kinase mediated cellular activity and agents useful in same
WO2004098627A1 (en) * 2003-05-06 2004-11-18 Royal College Of Surgeons In Ireland Inhibition of platelet aggregation through acyclovir and two peptide antagonists
WO2005037308A1 (en) * 2003-10-17 2005-04-28 Inter-K Pty Limited Methods and agents for the treatment of cancer
BRPI0608096A2 (en) 2005-04-26 2009-11-10 Pfizer p-cadherin antibodies
WO2008011513A2 (en) * 2006-07-19 2008-01-24 The Cleveland Clinic Foundation Compounds and methods of modulating angiogenesis
US8080252B2 (en) 2006-07-19 2011-12-20 The Cleveland Clinic Foundation Compounds and methods of modulating angiogenesis
JP2012533521A (en) 2008-07-17 2012-12-27 ニュートリペップ・ピーティーワイ・リミテッド Therapeutic agent
US8563690B2 (en) 2008-11-03 2013-10-22 The Board Of Trustees Of The University Of Illinois Modulation of platelet aggregation
CA3051855A1 (en) * 2017-01-27 2018-08-02 Vanderbilt University Fused in sarcoma (fus) nuclear translocation inhibitors for preventing fibrosis

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5114842A (en) * 1987-07-08 1992-05-19 The Scripps Research Institute Peptides and antibodies that inhibit platelet adhesion
CA2090427A1 (en) * 1990-08-27 1992-02-28 Cetus Oncology Corporation Cd18 peptide medicaments for the treatment of disease

Also Published As

Publication number Publication date
WO1998016241A1 (en) 1998-04-23

Similar Documents

Publication Publication Date Title
AU1909797A (en) Method of enabling handoff
AU5299696A (en) Methods of inhibiting cell-cell adhesion
AU6883798A (en) Method of anesthesia
AU4024395A (en) Cellular speakerphone and method of operation thereof
AU3770497A (en) Method of determining communications mode
AU1496697A (en) Method of increasing testosterone
AU2542397A (en) Method of preparing electrodes
AU2108997A (en) Adhesion inhibitors, preparation comprising them and method for producing them
AU5599598A (en) Inhibitors of glycosyltransferases
AU2568897A (en) Cyclic adhesion inhibitors
AUPO307196A0 (en) Method of controlled blasting
AU4815397A (en) Method of disrupting cellular adhesion
AU2277597A (en) New inhibitors of sh2-mediated processes
AU9501198A (en) Simplified training of voice dialing systems
AU1600597A (en) Stabilisation of polyolefin-recyclates
AU6064596A (en) Radio telephones and methods of operation
AU730990C (en) Method of improving shotcrete technology
AU1897397A (en) Method of manufacturing film-bonded can bodies
AU1787397A (en) Method of reception timing control
AUPO251896A0 (en) Method of manufacturing slotted component
AU7222596A (en) Method of decoration
AU7713896A (en) Method of producing an enterosorbent
AU1114497A (en) Enhanced time of arrival method
AU2796697A (en) Method of call forwarding
AU3105397A (en) Method and systems of telecommunication